Management Strategy

SAB & Senior Advisors

United by a shared vision of bringing drugs to patients in dire need, preeminent minds in drug development are brought together.

The work of SymBio Pharmaceuticals capitalizes on existing cutting-edge research and technologies in order to spur the clinical development and launch of sought after drug therapies in Japan.
Prominent clinical physicians and scientists, with track records of success and a wealth of experience in wide-ranging disciplines related to drug development, serve as advisors at SymBio. Together, the SAB and Senior Advisors render crucial decisions on SymBio's next drug targets and definitive steps to be taken, with the underlying goal of addressing  Enderserved medical needs' in Japan and other Asia-Pacific countries such as China, Korea, Taiwan and Singapore.

SAB & Senior Advisors
Senior Advisors